Categories
Sakar Healthcare Limited — Updates, 13-05-2026: Press Release
13-05-2026 · 09:13 am
Sakar Healthcare posts robust Q4FY26 results: revenue up 42% YoY (₹71.10 Cr), EBITDA soared 67% (₹26.24 Cr), PAT up 91% (₹11.02 Cr). Oncology advances with 12 marketing authorizations, 11 product approvals, & ongoing tech transfers, paving the way for strong FY27 growth.
No comments yet. Be the first to comment!